We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RPAY:NASDAQRepay Holdings Corporation Analysis

Data as of 2026-04-29 - not real-time

$4.06

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Repay Holdings (RPAY) is trading at $4.06, which sits above its 20‑day simple moving average yet remains under the 200‑day average, suggesting a short‑term upward bias within a longer‑term downtrend. The 14‑day RSI sits in the upper half of its range, indicating momentum but not yet overbought. A bullish MACD histogram reinforces the near‑term upside, while volume has been trending higher, adding credibility to the move. The stock’s beta is elevated, pointing to heightened sensitivity to market swings, and the 30‑day historical volatility exceeds 100%, underscoring a volatile price profile. Technical analysis shows the price comfortably above the identified support level of $2.30 and approaching a resistance near $4.29, leaving room for further gains. Meanwhile, the DCF‑derived fair value of roughly $5.93 implies a potential upside of over 60% from current levels.
Fundamentally, RPAY reports strong cash generation with operating cash flow exceeding $90 million and free cash flow above $60 million, offset by a negative operating margin and a high debt‑to‑equity ratio. The company’s forward P/E of about 4.3 and price‑to‑book below 1 suggest relative cheapness against industry peers, and analysts collectively rate the stock as a “Buy” with a median target near $7. Recent material news reveals that its largest shareholder, Forager Capital, has proposed a cash acquisition at $4.80 per share, representing a sizable premium and a catalyst that could unlock value. The combination of technical momentum, substantial upside to intrinsic value, and a potential transaction makes RPAY an attractive short‑ to medium‑term play, though the high volatility, leverage, and unprofitable margins warrant caution for long‑term holders.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 8/10

Key Factors

  • Bullish MACD crossover with rising volume
  • RSI in the upper half indicating momentum
  • Significant upside to DCF fair value

Medium Term

1–3 years
Positive
Model confidence: 9/10

Key Factors

  • Proposed cash acquisition at a premium
  • Strong operating and free cash flow generation
  • Analyst consensus buy rating with $7 median target

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • High beta and volatility increase systematic risk
  • Negative operating margins and high leverage
  • Long‑term industry tailwinds in digital payments

Key Metrics & Analysis

Financial Health

Revenue Growth0.40%
Profit Margin-83.01%
P/E Ratio4.3
ROE-43.20%
ROA-0.54%
Debt/Equity90.68
P/B Ratio0.7
Op. Cash Flow$91.1M
Free Cash Flow$61.5M
Industry P/E37.5

Technical Analysis

TrendNeutral
RSI64.8
Support$2.30
Resistance$4.29
MA 20$3.27
MA 50$3.06
MA 200$4.09
MACDBullish
VolumeIncreasing
Fear & Greed Index89.59

Valuation

Fair Value$5.93
Target Price$6.57
Upside/Downside61.86%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.58
Volatility122.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.